Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 24 May 23 424B3 Prospectus supplement
- 19 May 23 424B3 Prospectus supplement
- 15 May 23 EFFECT Notice of effectiveness
- 2 May 23 F-4/A Registration of securities (foreign) (amended)
- 13 Apr 23 F-4/A Registration of securities (foreign) (amended)
- 30 Mar 23 F-4/A Registration of securities (foreign) (amended)
-
13 Mar 23 F-4 Registration of securities (foreign)
AUMB similar filings
Filing view
External links
Exhibit 21.1
AUM BIOSCIENCES LIMITED
List of Subsidiaries
Upon completion of the Business Combination, AUM Biosciences Limited (“Holdco”)’s subsidiaries will be as follows:
Subsidiaries | Jurisdiction of Formation | Percentage of Economic Ownership | ||
AUM Biosciences Pte. Ltd. (“AUM”) | Singapore | 100% owned subsidiary of Holdco | ||
Mountain Crest Acquisition Corp. V (“Mountain Crest”) | Delaware, USA | 100% owned subsidiary of Holdco | ||
AUM Biosciences Suzhou | China | 100% owned subsidiary of AUM | ||
AUM Biosciences Inc. | Delaware, USA | 100% owned subsidiary of AUM | ||
AUM Australasia Pty Ltd. (“AUM Australia”) | Australia | 100% owned subsidiary of AUM | ||
AUM Biosciences Ptd Ltd. | Australia | 100% owned subsidiary of AUM Australia | ||
NuovoTRK Therapeutics Ptd Ltd. | Australia | 100% owned subsidiary of AUM Australia |